Discoveries by GNS Healthcare Causal Machine Learning and Simulation Platform, REFS, Reveal Mechanisms Driving Key Clinical Outcomes in Multiple Myeloma
Ongoing Collaboration Leveraging the Multiple Myeloma Research Foundation CoMMpass Study Reveals Drivers of High-Risk Disease and of Durable Response CAMBRIDGE, Mass. – December 6, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual […]
Xconomy Features Celgene-GNS REFS License, Investment Deal
Celgene has made a second investment in GNS Healthcare and is tapping into the firm’s data analytics software to boost Celgene’s drug discovery and development efforts. Read the full story here.
Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment
Partners to Apply Causal Machine Learning and Simulation to Combination Treatment Regimens to Discover Biomarkers of Clinical Response to Treatment CHICAGO, Ill. and CAMBRIDGE, Mass. – Dec. 15, 2015 – The Alliance for Clinical Trials in Oncology (the Alliance), one of the five cooperative research groups in the United States sponsored by the National Cancer […]
An Evening With Top Medical Innovators
Today’s visionaries battle cancer with cutting-edge science and the stubborness to make it work Surviving cancer requires teamwork. On the evening of Monday December 8, 2014, a small army of some of the best “soldiers” in the battle against blood cancer mingled with patients and members of the press in “The Swamp” at the California […]
GNS Healthcare CEO Colin Hill to Address AHIP Institute 2015 General Session
CAMBRIDGE, Mass. – May 26, 2015 – Precision medicine pioneer Colin Hill will be a featured speaker at AHIP Institute 2015, offering a real-world view of how precision medicine is converging with population health to enable truly individualized interventions and dramatically improve return on population health investments. Hill is chairman and CEO of GNS Healthcare, […]
GNS CEO attends announcement of Obama’s Precision Medicine Initiative at the White House – GNS CEO quoted by Politico
The White House on Friday unveiled a $215 million programto study genes of a million Americans in various stages of sickness and health, with the hope of gaining vast new insight into diseases and how to cure them. The kind of data crunching sponsored by the initiative can also help doctors figure out which patients […]
MMRF, GNS Healthcare to Collaborate on CoMMpass Study
GNS Healthcare and the Multiple Myeloma Research Foundation announced today an agreement to use GNS’ informatics solutions to explore genomic and clinical data from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, study. Read the complete article here…
GNS Healthcare Adds Two Leading Experts to Scientific Advisory Board
Dr. Richard Popiel and Dr. Atul Butte to Assist GNS as it Applies Machine Learning to Population Health Strategies CAMBRIDGE, Mass. – Dec. 17, 2014 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced the addition of Richard Popiel, MD, MBA and Atul Butte, […]